Scheriproct, Rektalsalbe

7680241370013 CH-24137 C05AA04 02.09.2.
Scheriproct, Rektalsalbe
Scheriproct, Rektalsalbe
Scheriproct, Rektalsalbe
1 / 3
google

Details

Product number
2413701
CPT
-
Packaging group
10
Unit
g
Composition
prednisoloni-21 hexanoas 1.9 mg, cinchocaini hydrochloridum 5 mg, octyldodecanolum, ricini oleum raffinatum, ricini oleum hydrogenatum, macrogoli 400 ricinoleas 75 mg, aromatica cum hydroxycitronellalum et hydroxycitronellalum et geraniolum et geraniolum et citronellolum et citronellolum et linaloolum et linaloolum et benzylis benzoas et benzylis benzoas et citralum et citralum et evernia prunastri et evernia prunastri et cinnamaldehydum et cinnamaldehydum et 3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-onum et 3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-onum et eugenolum et eugenolum et benzylis salicylas et benzylis salicylas et isoeugenolum et isoeugenolum et excipiens ad unguentum pro 1 g.

Articles (1)

Scheriproct, Rektalsalbe
Rektalsalbe
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2025
Patient information leaflet
Français
01/05/2025
Patient information leaflet
Italien
01/05/2025
Professional SmPC
Allemand
01/05/2025
Professional SmPC
Français
01/05/2025
Professional SmPC
Italien
01/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.9 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
75.0 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
24137
Drug name
Scheriproct, Rektalsalbe
Galenic form
REKS
ATC Code
C05AA04
Authorization status
Z
Dispensation category
B
First authorization
20/08/1958
Authorization expiration date
31/12/9999
IT number
02.09.2.
Domain
Human medicine
Field of application
Hämorrhoiden, oberflächliche Analfissuren, Proktitis

Packaging details

Description (FR)
SCHERIPROCT POMMADE RECTALE / 5 mg / 10 g
Description (DE)
SCHERIPROCT REKTAL SALBE / 5 mg / 10 g
Market launch
13/05/2025
Market withdrawal
13/05/2025
Narcotic (BTM)
No

Other packaging sizes

SCHERIPROCT POMMADE RECTALE / 5 mg / 30 g
30 G
View